Design Therapeutics, Inc.

NASDAQ:DSGN

6.25 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -13.039-11.793-11.105-11.842-15.789-19.937-19.294-17.34-17.704-14.999-13.265-11.065-11.318-7.636-5.514-3.855-2.32-1.442-0.663
Depreciation & Amortization -4.6070.1510.1430.1380.1370.1330.1290.1240.1080.0920.0820.0820.0310.0120.0040.0040.00100
Deferred Income Tax 0003.106-1.709-1.397000000.0260000000
Stock Based Compensation 3.1183.2993.1842.7243.2193.7193.4263.0762.8722.6172.361.5561.2431.2430.6470.4210.0150.010.004
Change In Working Capital 1.677-1.348-2.934-1.987-0.43.668-0.553-0.0631.2691.823-1.0370.161.85-1.931.3160.5880.5030.138-2.04
Accounts Receivables 0000000000000000000
Change In Inventory 0000000000000000000
Change In Accounts Payables 1.017-0.72-2.523-2.810.2393.07-1.7450.4083.1711.6060.2-0.0411.379-0.3011.3760000
Other Working Capital 0.66-0.628-0.4110.823-0.6390.5981.745-0.471-1.9020.217-1.2370.2011.85-1.93-0.060.5880.5030.138-2.04
Other Non Cash Items 3.3052.7524.2663.9790.0080.01-1.132-0.888-0.444-0.0330.0330.0140.030.022-0.15-0.002-0.058-0.0130.04
Operating Cash Flow -9.546-11.26-12.439-12.798-14.534-13.804-17.424-15.091-13.899-10.5-11.827-9.227-8.164-8.289-3.697-2.844-1.859-1.307-2.659
Investing Activities:
Investments In Property Plant And Equipment 0.016-0.161-0.195-0.027-0.053-0.089-0.087-0.288-0.31-0.244-0.076-0.354-0.968-0.183-0.033-0.014-0.06200
Acquisitions Net 0000.0320-0.012-0.020.0010.0630.039000000000
Purchases Of Investments -66.512-53.631-45.659-74.153-54.566-62.369-33.615-61.008-94.014-157.9760-49.905-4.319-26.926-5.1110-12.832-3.51-39.247
Sales Maturities Of Investments 60.6781.12566.4779.73569.88574.4453.43560.2430.9351.2250.490.20.2455.53828.1722.01216.0814.0110
Other Investing Activites 00.0270.0210.0060.0150.0120.02-0.001-0.0630.0390-0.05-0.004-0.0210.0230.0020.0030.001-0.039
Investing Cash Flow -5.82627.33320.6165.55515.26611.98219.733-1.056-63.389-156.9560.414-50.059-5.042-21.57123.0281.9983.1870.501-39.247
Financing Activities:
Debt Repayment 000000000000000000-0.2
Common Stock Issued -0.2490.2290.020.5010.0130.2100.130.1510.2250.1560.1930.030.005254.2710000
Common Stock Repurchased 0.223000.3050000.3390000.1940000000
Dividends Paid 0000000000000000000
Other Financing Activities 0.0010.2290.020.5010.0130.2100.130.151-0.2020.1560.1930.030.005124.7120.0010089.462
Financing Cash Flow 0.0010.2290.020.00100000-000000.3790.0010044.531
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000
Net Change In Cash -15.37116.3028.197-6.7420.745-1.6122.309-16.017-77.137-167.658-11.257-59.093-13.176-29.855398.314-0.8451.328-0.8062.625
Cash At End Of Period 30.32845.69929.39721.227.94227.19728.80926.542.517119.654287.312298.569357.662370.838400.6932.3793.2241.8962.702